250790-07-9

Basic information

• Product Name: Benzoic acid, 2-chloro-4-nitro-, phenylmethyl ester
• Synonyms: Benzoic acid,2-chloro-4-nitro-,phenylmethyl ester
• CAS NO: 250790-07-9
• Molecular Formula: C14H10ClNO4
• Molecular Weight: 291.691
• Mol File: 250790-07-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 438.0±35.0 °C(Predicted)
• Density: 1.377±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzoic acid, 2-chloro-4-nitro-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-chloro-4-nitro-, phenylmethyl ester(250790-07-9)
• EPA Substance Registry System: Benzoic acid, 2-chloro-4-nitro-, phenylmethyl ester(250790-07-9)

Safety Data

• Hazardous Substances Data: 250790-07-9(Hazardous Substances Data)

Upstream product

• 99-60-5 2-chloro-4-nitrobenzoic acid 
• 108-88-3 toluene 
• 100-39-0 benzyl bromide 

Downstream Products

• 250790-10-4 3'-benzyloxy-5-(6-benzyloxycarbonylamino-2-tert-butoxycarbonylamino-hexanoylamino)-biphenyl-2-carboxylic acid benzyl ester 
• 250790-08-0 3'-benzyloxy-5-nitro-biphenyl-2-carboxylic acid benzyl ester 
• 911314-07-3 4-amino-2-chloro-benzoic acid benzyl ester 

Relevant articles and documents

Linker Variation and Structure-Activity Relationship Analyses of Carboxylic Acid-based Small Molecule STAT3 Inhibitors

The molecular determinants for the activities of the reported benzoic acid (SH4-54), salicylic acid (BP-1-102), and benzohydroxamic acid (SH5-07)-based STAT3 inhibitors were investigated to design optimized analogues. All three leads are based on an N-met

ANTIANGIOGENIC DRUG TO TREAT CANCER, ARTHRITIS AND RETINOPATHY

Compounds having Formula (I) or pharmaceutically acceptable salts or prodrugs thereof, are useful for treating pathological states which arise from or are exacerbated by angiogenesis. The invention also relates to pharmaceutical compositions comprising th